logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Biotechnology Valuation An Introductory Guide The Wiley Finance Series 1st Edition Karl Keegan

  • SKU: BELL-1717208
Biotechnology Valuation An Introductory Guide The Wiley Finance Series 1st Edition Karl Keegan
$ 31.00 $ 45.00 (-31%)

4.1

10 reviews

Biotechnology Valuation An Introductory Guide The Wiley Finance Series 1st Edition Karl Keegan instant download after payment.

Publisher: Wiley
File Extension: PDF
File size: 2.61 MB
Pages: 216
Author: Karl Keegan
ISBN: 9780470511787, 9780470741344, 0470511788, 0470741341
Language: English
Year: 2009
Edition: 1

Product desciption

Biotechnology Valuation An Introductory Guide The Wiley Finance Series 1st Edition Karl Keegan by Karl Keegan 9780470511787, 9780470741344, 0470511788, 0470741341 instant download after payment.

* The first book to provide a simple and practical means of valuing biotech companies* The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips* It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US* Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them

Related Products